Product Information

TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLET is a generic product labeled by Strides Pharma Inc., priced at $0.2814 per EA under NDC 64380071404. Its NADAC has been published 457 times since Feb 21, 2018.

FDA first approved this application on Jan 26, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLET

tenofovir disoproxil fumarate
$0.2814per EA

Strength

300 mg/1

NDC

64380071404

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

11/18/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA090742

FDA Approved

1/26/2018

TE Code

AB

On Market Since

1/26/2018

Price Statistics

The NADAC for TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLET has been published 457 times since Feb 21, 2018, and over the history we have for it it has declined 99.0%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2814 per EA
All-time high$27.7425 (Mar 14, 2018)
All-time low$0.2814 (Nov 18, 2026)
52-week high$0.3671
52-week low$0.2814
Median price$0.5585
Average price$1.2074
Largest weekly change-87.4% (Apr 18, 2018)
Weeks tracked457
Tracking sinceFeb 21, 2018

Price History

1W

-4.8%

1M

-4.2%

3M

-9.5%

6M

-11.2%

1Y

-23.9%

3Y

-36.7%

5Y

-49.6%

All

-99.0%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLET, manufactured by Strides Pharma Inc., is $0.2814 per EA (NDC 64380071404), effective Nov 18, 2026.

How has the price of TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLET changed over time?

Over the history we have for it, the NADAC for TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLET has declined 99.0%. It has been tracked across 457 weekly CMS publications since Feb 21, 2018.

What are the highest and lowest recorded NADAC prices for TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLET?

Since Feb 21, 2018, the NADAC for TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLET has ranged from a low of $0.2814 (Nov 18, 2026) to a high of $27.7425 (Mar 14, 2018), with a median of $0.5585 per EA.

Are there cheaper alternatives to TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLET?

3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLET?

TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLET (NDC 64380071404) is labeled by Strides Pharma Inc., and CMS classifies it as a generic product.